JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C000639200 on September 27, 2000

J. Biol. Chem., Vol. 275, Issue 46, 35680-35683, November 17, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/46/35680    most recent
C000639200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ratcliffe, M. J.
Right arrow Articles by Sokol, S. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ratcliffe, M. J.
Right arrow Articles by Sokol, S. Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ACCELERATED PUBLICATION
A Positive Role for the PP2A Catalytic Subunit in Wnt Signal Transduction*

Marianne J. RatcliffeDagger, Keiji Itoh, and Sergei Y. Sokol

From the Department of Microbiology and Molecular Genetics, Harvard Medical School, Molecular Medicine Unit, Beth Israel Deaconess Medical Center, Boston, Massachessetts 02215

Received for publication, September 13, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein phosphatase-2A (PP2A) is a multisubunit serine/threonine phosphatase involved in intracellular signaling, gene regulation, and cell cycle progression. Different subunits of PP2A bind to Axin and Adenomatous Polyposis Coli, components of the Wnt signal transduction pathway. Using early Xenopus embryos, we studied how PP2A functions in Wnt signal transduction. The catalytic subunit of PP2A (PP2A-C) potentiated secondary axis induction and Siamois reporter gene activation by Dishevelled, a component of the Wnt pathway, indicating a positive regulatory role of this enzyme in Wnt signaling. In contrast, small t antigen, an antagonist of PP2A-C, inhibited Dishevelled-mediated signal transduction, as did the regulatory PP2A-B'epsilon subunit, consistent with the requirement of PP2A function in this pathway. Although Wnt signaling is thought to occur via regulation of beta -catenin degradation, PP2A-C did not significantly affect beta -catenin stability. Moreover, the pathway activated by a stabilized form of beta -catenin was sensitive to PP2A-C and its inhibitors, suggesting that PP2A-C acts downstream of beta -catenin. Because previous work has suggested that PP2A can act upstream of beta -catenin, we propose that PP2A regulates the Wnt pathway at multiple levels.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Wnt family of secreted glycoproteins regulates many biological processes including cell growth, cell polarity, and tissue specification (1-3). In Xenopus embryos, microinjection of RNAs encoding certain Wnts into ventral-vegetal blastomeres leads to generation of a secondary dorsal-ventral axis (4). Furthermore, inhibition of downstream Wnt signaling suppresses the formation of the primary axis (5, 6). Thus, activation of the Wnt pathway plays a key role in dorsal axis development in vertebrates.

Genetic and biochemical approaches have identified many components of the Wingless/Wnt signal transduction pathway. Wnts bind to transmembrane Frizzled receptors, which leads to activation of the cytoplasmic Dsh (Dishevelled) protein (7, 8). Dsh forms a complex with proteins of the Axin family (9-12), which also bind glycogen synthase kinase-3beta (GSK-3beta ),1 the adenomatous polyposis coli gene product (APC), protein phosphatase-2A (PP2A), and beta -catenin (13-16). In the absence of Wnt signaling, beta -catenin within this complex is phosphorylated by GSK-3, and this leads to its rapid degradation via the ubiquitin pathway (17). In response to Wnt signals, beta -catenin is no longer targeted for degradation and accumulates to high levels in the cytoplasm (18). This stabilized beta -catenin enters the nucleus and, complexed with transcription factors of the Lef-1/Tcf family, promotes the transcription of target genes (19, 20) such as Siamois (21).

The biochemical mechanism by which the Axin·GSK-3·APC·beta -catenin complex is regulated by Wnt signaling is not yet known. Regulation of phosphorylation is likely to play an important role, because Dsh, Axin, APC, GSK-3, and beta -catenin are all phosphoproteins. The serine/threonine phosphatase PP2A has a wide range of substrates and is important in many cellular processes. It comprises a regulatory A subunit, a catalytic C subunit, and variable regulatory B subunits, which may target the location and/or action of the holoenzyme (22-24). Mouse embryos lacking the PP2A-Calpha gene die 6.5 days post coitum, indicating that PP2A has a critical function during early development (25). PP2A-C was shown to bind to Axin (15), whereas regulatory subunits of the PP2A-B' family can interact with APC (26). Also, PP2A can promote dephosphorylation of both APC and Axin (27, 28). Overexpression of the PP2A-B'epsilon subunit causes a decrease in levels of beta -catenin in mammalian tissue culture cells (26). Although these observations indicate that PP2A may regulate beta -catenin degradation, the specific role of the catalytic subunit and the function of the holoenzyme in the Wnt pathway remain unclear.

We have used microinjection assays in Xenopus laevis to probe the action of PP2A in Wnt signaling. We show that PP2A-C is a necessary positive component of Wnt signaling in Xenopus. Unexpectedly, we find that PP2A can act downstream or parallel to beta -catenin, and it may serve to activate Tcf transcription factors. Because PP2A has also been shown to act upstream of beta -catenin, we propose that this enzyme regulates the Wnt pathway at multiple levels.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA Constructs-- The Siamois-luciferase reporter construct (pSia-Luc) (29), pE1b-luciferase (30), dominant negative GSK-3 (DN-GSK-3) (31), and the hemagglutinin-tagged form of Xenopus Dsh (Xdsh) (12) have been described previously. For synthesis of mRNA for injection experiments, bovine PP2A-Calpha was subcloned into pCS2 (33) using BamHI and EcoRI restriction sites; SV40 small t antigen was subcloned into pXT7 (31) via KpnI and BglII sites. Xenopus PP2A-B'epsilon cDNA was isolated in a yeast two hybrid screen using Xdsh as a bait, as described (12). Of the 189 positive clones isolated in this screen 67 were sequenced, and 9 encoded Xenopus PP2A-B'epsilon . The Xenopus PP2A-B'epsilon sequence has been deposited in GenBankTM under accession number AF298157. A cDNA comprising the entire coding sequence of PP2A-B'epsilon was subcloned into pXT7HA,2 using available restriction sites. Detailed cloning strategies are available on request. Stabilized and wild-type forms of Myc-beta -catenin, XBC26 and XBC40, (18) were a gift of David Kimelman; XTcf-3 (19) was a gift of Hans Clevers.

Xenopus Embryos, Microinjections, and Luciferase Assays-- These were performed as described previously (34). Luciferase activity data are presented as the average of triplicate samples, each comprising five embryos, and every experiment was reproduced on at least three separate occasions. The following amounts of RNA were injected: Xdsh, 500 or 125 pg as indicated; PP2A-B'epsilon , 200 or 50 pg; small t antigen, 50 pg; PP2A-Calpha , 1 ng; DN-GSK-3, 200 pg; stabilized beta -catenin (XBC26), 200 pg; and XTcf-3, 250 pg.

Protein Analysis-- For beta -catenin stability assays, Myc-beta -catenin RNA (XBC40; 50 pg) was injected into the two ventral animal cells at the 4-8-cell stage, alone or in the presence of PP2A-Calpha , small t antigen or DN-GSK-3beta RNA. Five embryos were harvested at stage 10.5 in 100 µl of lysis buffer (50 mM Tris·HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10 mM NaF, 1 mM Na3VO4), and cell debris and yolk platelets were removed by centrifugation at 14,000 rpm for 5 min. The supernatant was mixed 1:1 with 2× sample loading buffer (35), and samples were analyzed by standard SDS polyacrylamide gel electrophoresis and Western blotting procedures as described (12). Myc antibodies were from the 9E10 hybridoma (36), and beta -tubulin monoclonal antibodies were from Sigma.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

PP2A Is an Essential Positive Regulator of the Wnt Pathway-- The role of PP2A in Wnt signaling was studied using RNA microinjection assays in early frog embryos. Dsh is an essential component of the Wnt pathway and, when overexpressed, induces an ectopic secondary axis (37, 38). mRNA encoding the catalytic subunit of bovine PP2A (PP2A-Calpha ) was coinjected with mRNA for Xdsh into ventral-vegetal blastomeres of four cell-stage embryos. PP2A-Calpha did not inhibit the ability of Xdsh to induce a secondary axis nor was it able to induce a secondary axis when expressed alone (data not shown). When low doses of Xdsh were used such that secondary axes were often only partial and formed at lower frequencies, PP2A-Calpha was found to increase the incidence of secondary axis formation (Fig. 1A and B). Furthermore, a higher percentage of these axes were complete, as scored by the presence of eyes and cement gland (see Fig. 1 and Table I). This result shows that PP2A-C cooperates with Xdsh in axis induction.


View larger version (136K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of PP2A subunits on Xdsh signaling. mRNAs were injected into both ventral-vegetal blastomeres at the 8-cell stage. A, when Xdsh mRNA is injected at a low dose (125 pg), many embryos develop normally. Some embryos form partial secondary axes, lacking eyes and cement gland (arrowhead). B, coinjection of PP2A-Calpha with Xdsh (125 pg) leads to an increase in the proportion of embryos with secondary axes, and many of these have eyes and cement glands. C, Xdsh mRNA (500 pg); Xdsh induces a complete secondary axis when expressed at high levels. D, Xdsh (500 pg) + PP2A-B'epsilon ; PP2A-B'epsilon blocks the ability of Xdsh to induce a secondary axis.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Compiled data for effects of PP2A-C and PP2A-B'epsilon subunits on secondary axis induction by Xdsh
Embryo injections were done as described in the legend to Fig. 1. Axes were scored at stage 35. A secondary axis was scored as complete if it included eyes and a cement gland. Partial axis is defined as the presence of a secondary neural tube lacking head structures. Each injection point represents the combination of three separate experiments. n refers to the total number of embryos injected.

We also studied transcriptional activation of a reporter gene comprising the promoter for the Wnt target Siamois linked to luciferase (pSia-Luc) (27). This construct was coinjected with Xdsh mRNA into Xenopus ventral animal blastomeres at the 4-8-cell stage. Embryos were harvested at stage 10.5, and luciferase activity was assayed. This site of injection was chosen, because the pSia-Luc reporter alone is not significantly induced in ventral animal blastomeres (29). The reporter activity was up-regulated by Xdsh, and this activation was further increased by PP2A-Calpha (Fig. 2A). Together, these data suggest that the catalytic subunit of PP2A plays a positive role in Wnt signal transduction.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   PP2A-C is required for Xdsh signaling. DNAs for pSia-Luc or pE1b-Luc were injected alone or with mRNAs encoding Xdsh and/or PP2A-C antagonists into the animal pole of both ventral blastomeres at the 4-8-cell stage. Embryos were left to develop until stage 10.5 and were then harvested, and embryo lysates were assayed for luciferase activity. Aliquots of these samples were analyzed by Western blotting to confirm that the level of Xdsh expression was unaffected by PP2A subunits or inhibitors (data not shown). A, Xdsh (125 pg) induces pSia-Luc. This is increased 3-fold by coinjection of PP2A-Calpha RNA. B, activation of pSia-Luc by Xdsh (500 pg) is inhibited by Smt or by PP2A-B'epsilon . The activity of the control pE1b-Luc reporter is not inhibited by Smt or PP2A-B'epsilon . RLU, relative light units.

SV40 small t antigen (Smt) is a commonly used inhibitor of the catalytic subunit of PP2A (39). Overexpression of Smt completely blocked the ability of Xdsh to activate pSia-Luc (Fig. 2B). An E1b-luciferase promoter was used as a control to confirm that this decrease in signal from pSia-Luc was not because of nonspecific inhibition of basal transcription or translation in response to Smt. In fact, there was a slight increase in signal from the E1b-luciferase reporter (Fig. 2B) and a cytomegalovirus-luciferase reporter (data not shown) in the presence of Smt, suggesting that PP2A-C has a negative influence on transcription and/or translation. These data indicate that PP2A-C function is required for Wnt signal transduction.

The PP2A-B'epsilon Subunit Is an Antagonist of Xdsh-- In addition to Smt, regulatory B subunits of PP2A can modulate PP2A activity (40, 41). They have been proposed to target PP2A-C to specific cellular locations and/or confer substrate specificity (24, 42, 43). Biochemical studies of purified PP2A have shown that dissociation of the B subunit from the core enzyme (AC) leads to increased phosphatase activity, suggesting that B subunits can act as negative regulators of the catalytic subunit (40, 41). A cDNA encoding the PP2A-B'epsilon subunit was isolated in a yeast two-hybrid screen of a Xenopus gastrula cDNA library using Xenopus Dishevelled as a bait. This Xenopus PP2A-B'epsilon was highly conserved, revealing 96% identity with human PP2A-B'epsilon at the amino acid level (data not shown). Coinjection of mRNA encoding the Xenopus PP2A-B'epsilon subunit with Xdsh mRNA blocked the ability of Xdsh mRNA to induce a secondary axis (see Fig. 1, C and D and Table I). Furthermore, PP2A-B'epsilon , like Smt, inhibited activation of the pSia-Luc reporter by Xdsh (Fig. 2B) while slightly increasing activation of a control E1b-Luc reporter. Thus, overexpression of the PP2A-B'epsilon subunit has an effect opposite that of the catalytic subunit. These data are consistent with the hypothesis that the PP2A-B'epsilon subunit acts as a negative regulator of the catalytic subunit and further support a requirement of PP2A in Wnt signal transduction.

PP2A-C Acts Independently of beta -Catenin Stabilization-- In mammalian cells, overexpression of PP2A-B'epsilon leads to beta -catenin degradation (26), suggesting that PP2A-C may promote beta -catenin stabilization. This result could provide an explanation for the positive role of PP2A in Wnt signaling. To determine the effect of PP2A-C on the stability of beta -catenin, low doses (50 pg) of RNA encoding Myc-beta -catenin were injected with PP2A-Calpha or Smt RNAs into ventral animal blastomeres of Xenopus embryos at the 4-cell stage. Embryos were harvested for protein analysis at stage 10.5. PP2A-Calpha or Smt had no effect on the levels of Myc-beta -catenin (Fig. 3A). As a positive control, dominant negative GSK-3 RNA caused a clear increase in the levels of beta -catenin in the same experiment.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   PP2A acts downstream of beta -catenin. A, Myc-beta -catenin mRNA was injected into ventral animal blastomeres alone (Control) or in the presence of RNA encoding PP2A-Calpha , Smt, or DN-GSK-3. Myc-beta -catenin levels were assayed from embryos harvested at stage 10.5. beta -Tubulin serves as a loading control. B and C, pSia-Luc reporter DNA was coinjected with various mRNAs into the animal-ventral blastomeres of a 4-cell embryo. Luciferase activity was assayed at stage 10.5. B, PP2A-Calpha increases the activation of pSia-Luc by XBC26. C, small t antigen blocks the activation of pSia-Luc by XBC26. RLU, relative light units.

The inability of PP2A-C or Smt to affect beta -catenin levels suggested that the potentiation of Wnt signaling by PP2A-C might occur by a mechanism other than increasing beta -catenin stability. To investigate this possibility, we used a form of beta -catenin, XBC26, which lacks the N-terminal phosphorylation sites necessary for targeting to the ubiquitin-mediated degradation pathway (18). Injection of PP2A-Calpha RNA increased the induction of pSia-Luc by XBC26 RNA (Fig. 3B). Conversely, Smt inhibited activation of pSia-Luc by XBC26 (Fig. 3C). Activation was also blocked by high doses of PP2A-B'epsilon (data not shown). Thus the PP2A catalytic subunit plays a positive role in Wnt signaling that is downstream or parallel to beta -catenin stabilization.

Recent evidence has shown that Wnt signaling can be regulated at the level of Tcfs (44). Although XTcf-3 is required for transmission of the Wnt signal, when injected alone it is unable to induce transcription of dorsal-specific genes and instead acts as a repressor (19, 45). Consistent with these reports, we found that XTcf-3 mRNA was unable to induce pSia-Luc reporter activity when injected into animal-ventral blastomeres (Fig. 4). Furthermore, overexpression of XTcf-3 blocked activation of pSia-Luc by Xdsh. However, coinjection of XTcf-3 mRNA and PP2A-Calpha mRNA caused a significant increase in promoter activity (Fig. 4). This result suggests that PP2A-C may promote the conversion of XTcf-3 from a repressor to an activator.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   XTcf-3 switches from a repressor to an activator in the presence of PP2A-Calpha . pSia-Luc reporter DNA was coinjected with various mRNAs into the animal-ventral blastomeres of a 4-cell embryo. Luciferase activity was assayed at stage 10.5. Neither XTcf-3 nor PP2A-Calpha alone significantly activate pSia-Luc. XTcf-3 inhibits activation of pSia-Luc by Xdsh. When both XTcf-3 and PP2A-Calpha are injected together the reporter is activated.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this report, we show that PP2A plays a positive role in Wnt signal transduction. Coinjection of the catalytic subunit potentiates signaling by Xdsh, as assayed by the ability of Xdsh to induce a secondary axis or activate a Siamois-luciferase reporter. Inhibition of endogenous PP2A-C by small t antigen blocks the ability of Xdsh to activate Siamois, demonstrating that PP2A-C is required for Wnt signal transduction. These findings are unexpected, because previously published data suggested that PP2A-C might be an inhibitor of the pathway in mammalian cells (26).

The PP2A-B'epsilon regulatory subunit of PP2A has been shown to bind to APC and is a negative regulator of Wnt signaling (26). We isolated a highly conserved Xenopus homologue of PP2A-B'epsilon using a yeast two-hybrid screen for proteins interacting with Xdsh. However, we were unable to demonstrate binding of PP2A-B'epsilon to Xdsh in embryo lysates, suggesting that the binding may be weak or transient. Consistent with the earlier report (26), our data show that PP2A-B'epsilon inhibits axis induction by Xdsh. Thus, the PP2A-B'epsilon subunit acts in an opposite manner to the catalytic subunit and is likely to function as an antagonist of PP2A-C. Our in vivo experiments support biochemical studies in which the presence of certain regulatory B subunits was correlated with reduced activity of the enzyme (40, 41).

In mammalian tissue culture cells, Myc-beta -catenin levels are increased by okadaic acid, an inhibitor of PP2A-C (26). In our experiments we did not observe a significant change in the stability of beta -catenin in response to PP2A-C or Smt, whereas beta -catenin was clearly stabilized by dominant negative GSK-3 (Fig. 3A). The assay we used may not be sufficiently sensitive. It is also possible that PP2A may behave differently in mammalian and Xenopus systems. Such differences in the Wnt pathway have been previously documented for APC, a potential PP2A substrate that inhibits Wnt signaling in mouse cells (46) but activates the same pathway in Xenopus embryos (47).

Because PP2A had no discernable effect on beta -catenin stability in our experiments, we tested whether this phosphatase functions downstream of beta -catenin. We found that target gene activation by stabilized beta -catenin is potentiated by PP2A-C and blocked by Smt. Therefore, PP2A can regulate the pathway via a mechanism independent of beta -catenin stabilization.

We next tested the possibility that PP2A acts at the level of Tcfs, which are necessary downstream components of Wnt signal transduction. Tcfs function as transcriptional repressors (29, 45, 48), but they can be converted into activators of Wnt target genes when complexed with beta -catenin (19, 20, 49). In Xenopus, overexpression of XTcf-3 represses endogenous Wnt signaling in the dorsal marginal zone (45). We also found that XTcf-3 suppressed signaling by Xdsh or beta -catenin (Fig. 4 and data not shown). However, upon coinjection of XTcf-3 and PP2A-C, a Siamois reporter construct was markedly activated (Fig. 4). This result suggests that PP2A-C can promote the conversion of XTcf-3 from a repressor to an activator. We propose that endogenous PP2A-C levels are insufficient for activation of overexpressed XTcf-3, which therefore behaves as a repressor of Wnt signaling. However, when PP2A-C is provided in excess, XTcf-3 now behaves as a transcriptional activator. XTcf-3 is known to bind corepressor molecules such as C-terminal binding protein (45) or Groucho (50), and signaling by PP2A-C might relieve this repression. Although XTcf-3 may be a direct substrate for PP2A, it is also possible that one of the many pathways involving PP2A could integrate with Wnt signaling downstream of beta -catenin. These possibilities remain to be tested by future studies.

    ACKNOWLEDGEMENTS

We acknowledge the participation of Liza Konnikova at the initial stage of this work and for help in sequencing. We thank Marc Mumby, David Kimelman, Victor Shifrin, and Hans Clevers for plasmids and Barbara Brott for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by National Institutes of Health grants (to S. Y. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF298157.

Dagger To whom correspondence should be addressed: Dept. of Microbiology and Molecular Genetics, Harvard Medical School, Molecular Medicine Unit, RW 663, Beth Israel Deaconess Medical Center, East Campus, 330 Brookline Ave., Boston, MA 02215. Tel.: 617-667-3746; Fax: 617-667-2913; E-mail: mratclif@caregroup.harvard.edu.

Published, JBC Papers in Press, September 27, 2000, DOI 10.1074/jbc.C000639200

2 S. Sokol, unpublished information.

    ABBREVIATIONS

The abbreviations used are: GSK, glycogen synthase kinase; PP2A, protein phosphatase-2A; DN, dominant negative; Smt, small t antigen; APC, adenomatous polyposis coli; Luc, luciferase; X, Xenopus.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Cadigan, K. M., and Nusse, R. (1997) Genes Dev. 11, 3286-3305
2. Moon, R. T., Brown, J. D., and Torres, M. (1997) Trends Genet. 13, 157-162
3. Nusse, R., and Varmus, H. E. (1992) Cell 69, 1073-1087
4. Sokol, S., Christian, J. L., Moon, R. T., and Melton, D. A. (1991) Cell 67, 741-752
5. Heasman, J., Crawford, A., Goldstone, K., Garner-Hamrick, P., Gumbiner, B., McCrea, P., Kintner, C., Yoshida Noro, C., and Wylie, C. (1994) Cell 79, 791-803
6. Zeng, L., Fagotto, F., Zhang, T., Hsu, W., Vasicek, T. J., Perry, W. L., III, Lee, J. J., Tilghman, S. M., Gumbiner, B. M., and Costantini, F. (1997) Cell 90, 181-192
7. He, X., Saint-Jeannet, J.-P., Wang, Y., Nathans, J., Dawid, I., and Varmus, H. (1997) Science 275, 1652-1654
8. Yang-Snyder, J., Miller, J. R., Brown, J. D., Lai, C.-J., and Moon, R. T. (1996) Curr. Biol. 6, 1302-1306
9. Smalley, M. J., Sara, E., Paterson, H., Naylor, S., Cook, D., Jayatilake, H., Fryer, L. G., Hutchinson, L., Fry, M. J., and Dale, T. C. (1999) EMBO J. 18, 2823-2835
10. Kishida, S., Yamamoto, H., Hino, S., Ikeda, S., Kishida, M., and Kikuchi, A. (1999) Mol. Cell. Biol. 19, 4414-4422
11. Li, L., Yuan, H., Weaver, C. D., Mao, J., Farr, G. H., III, Sussman, D. J., Jonkers, J., Kimelman, D., and Wu, D. (1999) EMBO J. 18, 4233-4240
12. Itoh, K., Antipova, A., Ratcliffe, M. J., and Sokol, S. (2000) Mol. Cell. Biol. 20, 2228-2238
13. Itoh, K., Krupnik, V. E., and Sokol, S. Y. (1998) Curr. Biol. 8, 591-594
14. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. (1998) EMBO J. 17, 1371-1384
15. Hsu, W., Zeng, L., and Costantini, F. (1999) J. Biol. Chem. 274, 3439-3445
16. Nakamura, T., Hamada, F., Ishidate, T., Anai, K., Kawahara, K., Toyoshima, K., and Akiyama, T. (1998) Genes Cells 3, 395-403
17. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. (1997) EMBO J. 16, 3797-3804
18. Yost, C., Torres, M., Miller, J. R., Huang, E., Kimelman, D., and Moon, R. T. (1996) Genes Dev. 10, 1443-1454
19. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., and Clevers, H. (1996) Cell 86, 391-399
20. Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996) Nature 382, 638-642
21. Lemaire, P., Garrett, N., and Gurdon, J. B. (1995) Cell 81, 85-94
22. Millward, T. A., Zolnierowicz, S., and Hemmings, B. A. (1999) Trends Biochem. Sci. 24, 186-191
23. Mumby, M. C., and Walter, G. (1993) Physiol. Rev. 73, 673-699
24. Shenolikar, S. (1994) Annu. Rev. Cell Biol. 10, 55-86
25. Götz, J., Probst, A., Ehler, E., Hemmings, B., and Kues, W. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12370-12375
26. Seeling, J. M., Miller, J. R., Gil, R., Moon, R. T., White, R., and Virshup, D. M. (1999) Science 283, 2089-2091
27. Ikeda, S., Kishida, M., Matsuura, Y., Usui, H., and Kikuchi, A. (2000) Oncogene 19, 537-545
28. Willert, K., Shibamoto, S., and Nusse, R. (1999) Genes Dev. 13, 1768-1773
29. Fan, M. J., Gruning, W., Walz, G., and Sokol, S. Y. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 5626-5631
30. Wu, L., Rosser, D. S., Schmidt, M. C., and Berk, A. (1987) Nature 326, 512-515
31. Dominguez, I., Itoh, K., and Sokol, S. Y. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8498-8502
32. Green, D. D., Yang, S. I., and Mumby, M. C. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 4880-4884
33. Turner, D. L., and Weintraub, H. (1994) Genes Dev. 8, 1434-1447
34. Fan, M. J., and Sokol, S. Y. (1997) Development 124, 2581-2589
35. Laemmli, U. K. (1970) Nature 227, 680-685
36. Evan, G. I., Lewis, G. K., Ramsay, G., and Bishop, J. M. (1985) Mol. Cell. Biol. 5, 3610-3616
37. Sokol, S. Y., Klingensmith, J., Perrimon, N., and Itoh, K. (1995) Development 121, 1637-1647
38. Rothbacher, U., Laurent, M. N., Blitz, I. L., Watabe, T., Marsh, J. L., and Cho, K. W. Y. (1995) Dev. Biol. 170, 717-721
39. Yang, S. I., Lickteig, R. L., Estes, R., Rundell, K., Walter, G., and Mumby, M. C. (1991) Mol. Cell. Biol. 11, 1988-1995
40. Kamibayashi, C., Estes, R., Slaughter, C., and Mumby, M. C. (1991) J. Biol. Chem. 266, 13251-13260
41. Kamibayashi, C., Estes, R., Lickteig, R. L., Yang, S. I., Craft, C., and Mumby, M. C. (1994) J. Biol. Chem. 269, 20139-20148
42. Sontag, E., Nunbhakdi-Craig, V., Bloom, G. S., and Mumby, M. C. (1995) J. Cell Biol. 128, 1131-1144
43. McCright, B., Rivers, A. M., Audlin, S., and Virshup, D. M. (1996) J. Biol. Chem. 271, 22081-22089
44. Ishitani, T., Ninomiya-Tsuji, J., Nagai, S., Nishita, M., Meneghini, M., Barker, N., Waterman, M., Bowerman, B., Clevers, H., Shibuya, H., and Matsumoto, K. (1999) Nature 399, 798-802
45. Brannon, M., Brown, J. D., Bates, R., Kimelman, D., and Moon, R. T. (1999) Development 126, 3159-3170
46. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3046-3050
47. Vleminckx, K., Wong, E., Guger, K., Rubinfeld, B., Polakis, P., and Gumbiner, B. M. (1997) J. Cell Biol. 136, 411-420
48. Brannon, M., Gomperts, M., Sumoy, L., Moon, R. T., and Kimelman, D. (1997) Genes Dev. 11, 2359-2370
49. Brunner, E., Peter, O., Schweizer, L., and Basler, K. (1997) Nature 385, 829-833
50. Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H., Moerer, P., van de Wetering, M., Destrée, O., and Clevers, H. (1998) Nature 395, 608-612


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J DAIRY SCIHome page
C. M. Stiening, J. B. Hoying, M. B. Abdallah, A. M. Hoying, R. Pandey, K. Greer, and R. J. Collier
The Effects of Endocrine and Mechanical Stimulation on Stage I Lactogenesis in Bovine Mammary Epithelial Cells
J Dairy Sci, March 1, 2008; 91(3): 1053 - 1066.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H. Tran, F. Hamada, T. Schwarz-Romond, and M. Bienz
Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains
Genes & Dev., February 15, 2008; 22(4): 528 - 542.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Bhasin, S. R. Cunha, M. Mudannayake, M. S. Gigena, T. B. Rogers, and P. J. Mohler
Molecular basis for PP2A regulatory subunit B56{alpha} targeting in cardiomyocytes
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H109 - H119.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
I. Nazarenko, R. Schafer, and C. Sers
Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
J. Cell Sci., April 15, 2007; 120(8): 1393 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Miyabayashi, J.-L. Teo, M. Yamamoto, M. McMillan, C. Nguyen, and M. Kahn
Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency
PNAS, March 27, 2007; 104(13): 5668 - 5673.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. L. Bos, S. H. Diks, J. C.H. Hardwick, K. V. Walburg, M. P. Peppelenbosch, and D. J. Richel
Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/{beta}-catenin pathway activity
Carcinogenesis, December 1, 2006; 27(12): 2371 - 2382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Van Kanegan, D. G. Adams, B. E. Wadzinski, and S. Strack
Distinct Protein Phosphatase 2A Heterotrimers Modulate Growth Factor Signaling to Extracellular Signal-regulated Kinases and Akt
J. Biol. Chem., October 28, 2005; 280(43): 36029 - 36036.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J. B. Wallingford and R. Habas
The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity
Development, October 15, 2005; 132(20): 4421 - 4436.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Uren, S. Fallen, H. Yuan, A. Usubutun, T. Kucukali, R. Schlegel, and J. A. Toretsky
Activation of the Canonical Wnt Pathway during Genital Keratinocyte Transformation: A Model for Cervical Cancer Progression
Cancer Res., July 15, 2005; 65(14): 6199 - 6206.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Salahshor and J R Woodgett
The links between axin and carcinogenesis
J. Clin. Pathol., March 1, 2005; 58(3): 225 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Swiatek, I-C. Tsai, L. Klimowski, A. Pepler, J. Barnette, H. J. Yost, and D. M. Virshup
Regulation of Casein Kinase I{epsilon} Activity by Wnt Signaling
J. Biol. Chem., March 26, 2004; 279(13): 13011 - 13017.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Matsubayashi, S. Sese, J.-S. Lee, T. Shirakawa, T. Iwatsubo, T. Tomita, and S.-i. Yanagawa
Biochemical Characterization of the Drosophila Wingless Signaling Pathway Based on RNA Interference
Mol. Cell. Biol., March 1, 2004; 24(5): 2012 - 2024.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
E. Saez, J. Rosenfeld, A. Livolsi, P. Olson, E. Lombardo, M. Nelson, E. Banayo, R. D. Cardiff, J. C. Izpisua-Belmonte, and R. M. Evans
PPAR{gamma} signaling exacerbates mammary gland tumor development
Genes & Dev., March 1, 2004; 18(5): 528 - 540.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. Bajpai, K. Makhijani, P. R. Rao, and L. S. Shashidhara
Drosophila Twins regulates Armadillo levels in response to Wg/Wnt signal
Development, March 1, 2004; 131(5): 1007 - 1016.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J. Yang, J. Wu, C. Tan, and P. S. Klein
PP2A:B56{epsilon} is required for Wnt/{beta}-catenin signaling during embryonic development
Development, December 1, 2003; 130(23): 5569 - 5578.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Y. Xing, W. K. Clements, D. Kimelman, and W. Xu
Crystal structure of a {beta}-catenin/Axin complex suggests a mechanism for the {beta}-catenin destruction complex
Genes & Dev., November 15, 2003; 17(22): 2753 - 2764.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Hannus, F. Feiguin, C.-P. Heisenberg, and S. Eaton
Planar cell polarization requires Widerborst, a B' regulatory subunit of protein phosphatase 2A
Development, March 9, 2003; 129(14): 3493 - 3503.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. D. Everett, C. Kamibayashi, and D. L. Brautigan
Transgenic expression of protein phosphatase 2A regulatory subunit B56gamma disrupts distal lung differentiation
Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1266 - L1271.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z.-H. Gao, J. M. Seeling, V. Hill, A. Yochum, and D. M. Virshup
Casein kinase I phosphorylates and destabilizes the beta -catenin degradation complex
PNAS, January 24, 2002; (2002) 32468199.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. van de Water, M. van de Wetering, J. Joore, J. Esseling, R. Bink, H. Clevers, and D. Zivkovic
Ectopic Wnt signal determines the eyeless phenotype of zebrafish masterblind mutant
Development, October 15, 2001; 128(20): 3877 - 3888.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yamamoto, T. Hinoi, T. Michiue, A. Fukui, H. Usui, V. Janssens, C. Van Hoof, J. Goris, M. Asashima, and A. Kikuchi
Inhibition of the Wnt Signaling Pathway by the PR61 Subunit of Protein Phosphatase 2A
J. Biol. Chem., July 13, 2001; 276(29): 26875 - 26882.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z.-H. Gao, J. M. Seeling, V. Hill, A. Yochum, and D. M. Virshup
Casein kinase I phosphorylates and destabilizes the beta -catenin degradation complex
PNAS, February 5, 2002; 99(3): 1182 - 1187.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/46/35680    most recent